Cytosorbents Corporation develops and commercializes medical devices using blood purification technology with its proprietary adsorbent and porous polymer technology platform. CytoSorb is the company's flagship product used in treating sepsis, maintaining organ quality for transplants, preventing complications in cardiopulmonary bypass surgery, and other critical care applications. Other products in development include VetResQ, CytoSorb-XL, HemoDefend, K+ontrol, BetaSorb, DrugSorb, and DrugSorb-ATR.